Nicole Lévy

Swiss Group For Clinical Cancer Research — Switzerland

Immunology and Microbiology · Life Sciences

8h-index616citations13works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(6), Immune Cell Function and Interaction(5), vaccines and immunoinformatics approaches(5), Glioma Diagnosis and Treatment(3), T-cell and B-cell Immunology(2)

Publications13 total

A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumors
Investigational New Drugs·2019· 12 citedOpen Access
IMMU-18. TARGETING THE PD1 AND TIGIT CHECKPOINT PATHWAYS FOR ADULT AND PEDIATRIC GLIOMAS
Neuro-Oncology·2018Open Access
Phase 1/2a study of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors.
Journal of Clinical Oncology·2018· 1 cited
A phase I study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of BAL101553, a novel tumor checkpoint controller (TCC), administered as 48-hour infusion in adult patients with advanced solid tumors.
Journal of Clinical Oncology·2017
Cross-presenting human γδ T cells induce robust CD8 <sup>+</sup> αβ T cell responses
Proceedings of the National Academy of Sciences·2009· 259 citedOpen Access
Identification of tumor-associated antigens by large-scale analysis of genes expressed in human colorectal cancer.
PubMed·2008· 39 citedOpen Access
Factoring in Antigen Processing in Designing Antitumor T-Cell Vaccines
Translational medicine series·2008
An optimized T cell epitope forecast approach for the identification of new human antigenic peptides derived from tumor-expressed splice variants
European Cells & Materials·2007
Molecular and immunological evaluation of the expression of cancer/testis gene products in human colorectal cancer
Cancer Immunology Immunotherapy·2006· 32 citedOpen Access
Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls<i>In vivo</i>T-Cell Responses
Cancer Research·2006· 63 cited
Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100209-217 and gp100209-217T210M
Cancer Immunology Immunotherapy·2004· 13 citedOpen Access
The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases
The Journal of Immunology·2002· 88 citedOpen Access
Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: Implications for inflammatory bowel diseases
PROTEOMICS·2002· 109 cited

Frequent Co-authors

Frédéric Lévy(8), Catherine Servis(5), Pedro M. Sousa Alves(4), Pedro Romero(3), Anne-Lise Peitrequin(3), Maha Ayyoub(3), Sébastien Viatte(3), Markus Joerger(3), Anastasios Stathis(3), Dagmar Hess(3), Marc Engelhardt(3), Patrice Larger(3), Heidi A. Lane(3), Silvia Stuedeli(3), Cristiana Sessa(3), Sandra Morel(2), Benoı̂t J. Van den Eynde(2), Laurence Chapatte(2), Hanifa Bouzourène(2), Grégory Theiler(2)